08:00 , Jan 12, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Guanylate binding protein 1 interferon-inducible (GBP1) In vitro and mouse studies suggest inhibiting GBP1 could...